Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
about
Chronic levodopa treatment alters expression and function of dopamine D3 receptor in the MPTP/p mouse model of Parkinson's disease.Monoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesCharacterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuseThe role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned ratsL-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission.D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesiaUpregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesias.Molecular imaging of levodopa-induced dyskinesias.Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.Advances in dopamine receptor agonists for the treatment of Parkinson's disease.The dopamine D3 receptor, a quarter century later.Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders.Dopamine agonists and pathologic behaviors.Effect of cyclosporin A on the uptake of D3-selective PET radiotracers in rat brain.Understanding and prevention of "therapy-" induced dyskinesias.PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.Synthesis and pharmacological evaluation of fluorine-containing D₃ dopamine receptor ligands.Synthesis and in vitro pharmacological evaluation of indolyl carboxylic amide analogues as D3 dopamine receptor selective ligands.Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease.Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling.Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.A late appearance by the dopamine D-3 receptor.Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression.Selectivity of probes for PET imaging of dopamine D3 receptors.
P2860
Q27307938-D77727ED-2218-46F4-B2D0-E5BEFAAF74A2Q28066691-A694CF09-DB1F-42BC-BF9B-6911B223D72AQ28275963-B6245CCD-5B1C-4B1D-81D0-04E05F36FB53Q28482094-C3E0B62D-EA65-43B6-B621-50E6A5A25770Q35424424-629F22E0-6A63-4508-A78C-9F09D5FD5C26Q36521275-5D188449-B4D9-4551-B594-C4A59FFA2653Q36727004-862AA1D1-614F-4DA2-8B4B-FE22BF183A9EQ37680849-71BBD958-B692-47DB-AEDE-7603478E9D7FQ37925513-CED2DDB8-28DB-438B-BFE3-BE122B2FC0B7Q38314257-3440D245-4FC9-46FD-8479-5BBF787A9BE4Q38355582-90CA7522-350C-42E1-8C7C-7440E0DDD25BQ38532889-DA53F190-B9C1-48BE-B1F2-CC7F9A46B370Q38937096-128A84EE-4CDD-4FD9-B75B-2A06D9FB6CAAQ38947750-CDD4FCBB-4C19-4073-8C33-E882E920C3E7Q39067400-777EA2EF-C1F5-48FE-8A42-553D3D5850B9Q39620073-E1CDB0CB-E25E-4C76-B3E1-8122F59CB8F7Q42035376-0EC08104-83EF-4E4D-95BA-843C099DBFFCQ42052125-E6CD71F0-709E-488C-BCC9-E9ECCE9C42C5Q42369736-CABE3563-B725-4F99-9419-5917BE2CC781Q42705882-4D3F4377-E630-42ED-856D-374F431A010BQ42940046-D0D2E355-2DE3-4586-9BFB-C2405CD52C4FQ43121312-44E3B669-CD5E-4C47-8002-AC92C6F90F21Q47637177-0649282B-1996-4B8D-ABAF-A322112EE33CQ48475595-9C9EA7D8-8E44-45CF-90DC-8951000252DFQ48648244-5B9C676B-276D-435C-BC4D-76C58AC920ACQ49357267-85471CEA-EFD1-4D53-B746-1DE07FABDBE2Q52316241-56FBC641-80C5-427C-9E37-C20197DBDE52
P2860
Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Dopamine D3 receptor stimulati ...... models of Parkinson's disease.
@en
Dopamine D3 receptor stimulati ...... models of Parkinson's disease.
@nl
type
label
Dopamine D3 receptor stimulati ...... models of Parkinson's disease.
@en
Dopamine D3 receptor stimulati ...... models of Parkinson's disease.
@nl
prefLabel
Dopamine D3 receptor stimulati ...... models of Parkinson's disease.
@en
Dopamine D3 receptor stimulati ...... models of Parkinson's disease.
@nl
P2093
P50
P921
P1476
Dopamine D3 receptor stimulati ...... models of Parkinson's disease
@en
P2093
Gabriela Reyes
Mark J Millan
Susan H Fox
P304
P356
10.1016/J.NBD.2008.11.010
P577
2008-12-09T00:00:00Z